| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f589d0b83263e9cfc0d9ce572b299429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba87976998967836df41bfa64645aab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b1dbd15ac186e7c2e69601beb1c6aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3ebbcade5214de99bc2f20192b72094 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-2093 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_326c6ca98f0e1453eb67c258f09f6a78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae84e3e96e88fdfd7ac7d90031479923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f7c10c0f78b9ccbaf838281c453f99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5f739330d14fd6a8ed8862663db6362 |
| publicationDate |
2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010092446-A1 |
| titleOfInvention |
Drug solution having reduced dissolved oxygen content, method of producing the same and drug solution containing unit having reduced dissolved oxygen content |
| abstract |
It is an object of the present invention to provide a drug solution which has a reduced dissolved oxygen content and is less susceptible to oxidative degradation and highly stable over time, a production method therefor, and a drug solution containing pack which is capable of maintaining the dissolved oxygen content of a drug solution at a reduced level, less susceptible to oxidative degradation of the drug solution and highly stable over time. To achieve the aforementioned object, the reduced-dissolved-oxygen-content drug solution is produced by filling and sealing the drug solution in a drug solution container ( 15 ) formed of a plastic material having an oxygen permeability of not lower than 200 cm 3 /m 2 ·24 h·atm at 25° C. at 60% RH within 12 hours after a steam sterilization process or a hot water sterilization process and having a steady-state oxygen permeability of not higher than 100 cm 3 /m 2 ·24 h·atm at 25° C. at 60% RH, subjecting the drug solution container to the steam sterilization process or the hot water sterilization process, and storing the drug solution container in an environment having deoxidization means for reducing the dissolved oxygen concentration of the drug solution to not higher than 2 ppm when the oxygen permeability of the plastic material reaches the steady-state level. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3973950-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022063963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013114034-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013114003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009214807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104136044-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022378077-A1 |
| priorityDate |
2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |